Jefferies Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$2.49K 2101
2025
Q4
$2.49K Hold
100
﹤0.01% 1821
2025
Q3
$2.55K Hold
100
﹤0.01% 1423
2025
Q2
$2.42K Sell
100
-14,000
-99% -$326K ﹤0.01% 1243
2025
Q1
$357K Sell
14,100
-82,000
-85% -$2.15M ﹤0.01% 1160
2024
Q4
$2.55M Hold
96,100
0.02% 586
2024
Q3
$2.78M Sell
96,100
-300,000
-76% -$8.75M 0.02% 483
2024
Q2
$11.1M Buy
396,100
+235,900
+147% +$6.49M 0.12% 141
2024
Q1
$4.45M Sell
160,200
-75,400
-32% -$2.09M 0.04% 332
2023
Q4
$6.78M Buy
+235,600
New +$7.12M 0.04% 320
2023
Q1
Sell
-110,000
Closed -$5.64M 1904
2022
Q4
$5.64M Buy
+110,000
New +$5.27M 0.04% 373

Other funds holding PFE

Jefferies Financial Group's PFE Position: Q1 2026 in Review

Jefferies Financial Group reduced its Pfizer (PFE) stake by 25% in Q1 2026, selling an estimated $8.17M and leaving 923,320 shares worth $25.9M. The position accounts for 0.18% of the portfolio, ranked #94.

Jefferies Financial Group first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $35.3M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Jefferies Financial Group held 923,320 shares of Pfizer worth $25.9M as of Q1 2026.
  • Jefferies Financial Group sold 306,961 Pfizer shares in Q1 2026, an estimated $8.17M.
  • Pfizer made up 0.18% of Jefferies Financial Group's portfolio in Q1 2026, its #94 holding.
  • Jefferies Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Pfizer position peaked at $35.3M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.